Katie Good, PA
Physician Assistant · San Marcos, TXNPI 1093966178
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $378 of the $546 with a category attached, or 69.2%. It is spread thinly across 10 manufacturers, the largest accounting for just 23.8%.
Across 20 payments — averaging $27.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$130
- Johnson & Johnson$122
- Bristol Myers Squibb$62
- Stemline Therapeutics Inc.$56
- Novartis$39
- Daiichi Sankyo Inc.$38
- plus $100 from 4 others
Across 2 payments — averaging $17,014 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$34K
What the payments were for
- Food & beverage$37869%
- Education$16831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $130 |
| Johnson & Johnson | 2 | $122 |
| Bristol Myers Squibb | 3 | $62 |
| Stemline Therapeutics Inc. | 3 | $56 |
| Novartis | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Gilead | 1 | $31 |
| Incyte Corporation | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
How this compares
$546 in reported general payments places this provider in the 55th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 17 | $484 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $239 |
| Ondansetron OdtOndansetron | 15 | $230 |
| Clotrimazole | 12 | $185 |
| Prochlorperazine Maleate | 18 | $167 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in San Marcos
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.